A new treatment for narcolepsy improved people’s ability to stay awake and reduced their weekly episodes of cataplexy, or sudden muscle weakness, compared with placebo, according to results from an 8-week clinical trial that included 73 participants. Currently, people with narcolepsy manage their condition with multiple medications that often do not control all their symptoms.
Fuente del artículo
Relacionado:
Clinical trial leader on first FDA-approved pill for postpartum depression : NPR
effective doses in radiology and diagnostic nuclear medicine a catalog
A podcast for patients and families on deciding between the ED and Urgent Care – PEMBlog
